Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.
Maria Ukhanova, MD, PhD
Advertisement
Articles by Maria Ukhanova, MD, PhD
Little is known about opioid prescribing patterns in patients with chronic overlapping pain conditions. This study suggests target populations for interventions to manage chronic pain.
Advertisement
Latest Updated Articles
Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing PatternsPublished: August 15th 2025 | Updated:
- Chronic Overlapping Pain Conditions and Long-term Opioid Treatment
Published: May 17th 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
2
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
3
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
4
Evaluating Current Breast Cancer Care, Treatments: Lakshminarayanan Nandagopal, MD
5
